Month: December 2020

Here it is, December of 2020. It’s been the Year of the Pandemic, and possibly also the Year of Increased Drinking. A September 29 ABC News story reported a sharp increase in U.S. alcohol consumption—especially among women—perhaps as a way to cope with feelings of isolation, depression and anxiety. keep reading

Here is fantastic news for men who undergo an initial treatment for localized prostate cancer! In November, 2020 the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to RV001, an investigational vaccine against prostate cancer recurrence after primary treatment. RV001 is manufactured by a Swedish pharmaceutical company called RhoVac. Let’s look at the keep reading